MX2010007374A - Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. - Google Patents
Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos.Info
- Publication number
- MX2010007374A MX2010007374A MX2010007374A MX2010007374A MX2010007374A MX 2010007374 A MX2010007374 A MX 2010007374A MX 2010007374 A MX2010007374 A MX 2010007374A MX 2010007374 A MX2010007374 A MX 2010007374A MX 2010007374 A MX2010007374 A MX 2010007374A
- Authority
- MX
- Mexico
- Prior art keywords
- keto
- novel
- derivatives preparation
- sup
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a compuestos 21-cetotriterpeno de formula (I): en donde R1, X e Y son como se define en la presente , y sales y solvatos de los mismos farmacéuticamente aceptables. Estos compuestos exhiben actividad anti-VIH significativa. Por lo siguiente la invención también se refiere a métodos para la prevención o tratamiento de infecciones por VIH administrando cantidades terapéuticamente efectivas de un compuesto de fórmula (I), o una sal o solvato del mismo farmacéuticamente aceptable a un sujeto en necesidad de tal tratamiento.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1876608P | 2008-01-03 | 2008-01-03 | |
US3968008P | 2008-03-26 | 2008-03-26 | |
PCT/CA2008/002290 WO2009082818A1 (en) | 2008-01-03 | 2008-12-23 | Novel c-21-keto lupane derivatives preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010007374A true MX2010007374A (es) | 2010-10-05 |
Family
ID=40823728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010007374A MX2010007374A (es) | 2008-01-03 | 2008-12-23 | Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2240504A1 (es) |
JP (1) | JP2011508747A (es) |
CN (1) | CN101977924A (es) |
AU (1) | AU2008342536A1 (es) |
CA (1) | CA2711420A1 (es) |
MX (1) | MX2010007374A (es) |
WO (1) | WO2009082818A1 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2254582B1 (en) * | 2008-01-25 | 2016-01-20 | Chimerix, Inc. | Methods of treating viral infections |
US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
DK3494972T3 (da) | 2010-01-27 | 2024-01-29 | Viiv Healthcare Co | Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion |
AU2011215986A1 (en) * | 2010-02-11 | 2012-08-30 | Glaxosmithkline Llc | Derivatives of betulin |
US9006218B2 (en) | 2010-02-12 | 2015-04-14 | Chimerix Inc. | Nucleoside phosphonate salts |
EP2563367A4 (en) | 2010-04-26 | 2013-12-04 | Chimerix Inc | METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES |
WO2013020245A1 (en) * | 2011-08-08 | 2013-02-14 | Glaxosmithkline Llc | Carbonyl derivatives of betulin |
CN104844679B (zh) * | 2011-12-16 | 2017-03-01 | 葛兰素史克有限责任公司 | 白桦脂醇的衍生物 |
JO3387B1 (ar) * | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
CN103242413B (zh) * | 2012-02-08 | 2015-08-26 | 江西青峰药业有限公司 | Lupane三萜系衍生物及其药学用途 |
WO2014093941A1 (en) * | 2012-12-14 | 2014-06-19 | Glaxosmithkline Llc | Pharmaceutical compositions |
US9637516B2 (en) | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
CN106999425A (zh) | 2014-09-26 | 2017-08-01 | 葛兰素史克知识产权第二有限公司 | 长效药物组合物 |
MA40886B1 (fr) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih |
WO2016147099A2 (en) * | 2015-03-16 | 2016-09-22 | Hetero Research Foundation | C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors |
WO2017115329A1 (en) * | 2015-12-30 | 2017-07-06 | Hetero Research Foundation | C-3 novel triterpenone derivatives as hiv inhibitors |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
-
2008
- 2008-12-23 MX MX2010007374A patent/MX2010007374A/es not_active Application Discontinuation
- 2008-12-23 EP EP08867782A patent/EP2240504A1/en not_active Withdrawn
- 2008-12-23 CN CN2008801275023A patent/CN101977924A/zh active Pending
- 2008-12-23 CA CA2711420A patent/CA2711420A1/en not_active Abandoned
- 2008-12-23 AU AU2008342536A patent/AU2008342536A1/en not_active Abandoned
- 2008-12-23 WO PCT/CA2008/002290 patent/WO2009082818A1/en active Application Filing
- 2008-12-23 JP JP2010540996A patent/JP2011508747A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2711420A1 (en) | 2009-07-09 |
CN101977924A (zh) | 2011-02-16 |
WO2009082818A8 (en) | 2009-09-03 |
WO2009082818A1 (en) | 2009-07-09 |
EP2240504A1 (en) | 2010-10-20 |
JP2011508747A (ja) | 2011-03-17 |
AU2008342536A1 (en) | 2009-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010007375A (es) | Nuevos derivados de lupano. | |
MX2010007374A (es) | Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. | |
MX2021013075A (es) | Oxisteroles y metodos de uso de los mismos. | |
MX2022013596A (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
PH12017501426A1 (en) | Derivatives of betulin | |
TN2015000121A1 (en) | Gdf-8 inhibitors | |
WO2012142093A3 (en) | 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
PH12021551256A1 (en) | Pantetheine derivatives and uses thereof | |
EP4316591A3 (en) | Oxysterols and methods of use thereof | |
WO2008132138A9 (en) | AMINOPYRIMIDINE DERIVATIVES DISUBSTITUTED IN 4 AND 6 | |
MX2014015158A (es) | Derivados de piridinona y piridazinona. | |
WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
TN2019000170A1 (en) | Tetracyclic heterocycle compounds useful as hiv integrase inhibitors | |
PH12015501560A1 (en) | Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
MX2011013648A (es) | Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos. | |
NZ600912A (en) | Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection | |
EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
IN2012DN02502A (es) | ||
MX2020011317A (es) | Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih. | |
WO2014172188A3 (en) | 4-pyridone derivative compounds and uses thereof as hiv integrase inhibitors | |
MX2021012223A (es) | Compuestos de hexahidro-1h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria. | |
MX2013002620A (es) | Novedosas n-hidroxi-benzamidas para el tratamiento del cancer. | |
MX2012004835A (es) | Derivados de espirolactama y usos de los mismos. | |
JO2725B1 (en) | Quinoline antibacterial derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |